Radiofrequency Treatment Better Than Ethanol Injection for Small Liver Tumours
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Radiofrequency Treatment Better Than Ethanol Injection for Small Liver Tumours

HOBOKEN, NJ -- February 4, 2009 -- A review of 4 randomised controlled trials that directly compared 2 different treatments for small inoperable liver tumours found that radiofrequency ablation (RFA) significantly improves patient survival compared with percutaneous ethanol injection (PEI). The findings are published in the February issue of Hepatology.

Guidelines from the American Association for the Study of Liver Diseases (AASLD) recommend PEI as a safe and highly effective treatment for small hepatocellular carcinomas and say it is the standard against which new therapies should be compared.

Yun Ku Cho, MD, Department of Radiology, Seoul Veterans Hospital, Seoul, Korea, and colleagues conducted a systematic review and meta-analysis of randomised controlled trials to determine the benefit of RFA compared with PEI.

Using databases and manual searches, they identified all relevant, peer-reviewed studies published from 1978 through July 2008. Ultimately, only 4 studies, which included a total of 652 patients, contained enough information for a meta-analysis of 3-year overall survival.

"Most randomised controlled trials identified definite survival benefit favoring RFA compared with PEI except the latest trial published in 2008," the authors said. The meta-analysis also detected a significant improvement in 3-year survival for patients who underwent RFA.

"The additional survival benefit of RFA can be attributed to improved local tumour response of RFA, which in turn can be explained by the fact that more predictable tumour ablation was possible," the authors suggested. While injected ethanol might be stopped by the liver's fibrous septum or by satellite nodules, the heat from the radiofrequency electrode tip is distributed more homogenously.

SOURCE: Wiley-Blackwell

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities